In
MATERIALS AND METHODSSerum (500 cm3) was obtained by plasmapheresis from patient Od, who had advanced hepatoma, 2 weeks prior to death. Ascitic fluid (2000 cm3) and tumor tissue (300 g) were obtained at autopsy. The tumor tissue was homogenized in 5 volumes of 10 mM phosphate-buffered 0.15 M NaCl (pH 7.4) and cleared of particulate matter by ultracentrifugation at 120,000 X g for 2 hr. Concentrations of a-fetoprotein in the serum, ascitic fluid, and tumor homogenate were 200, 150, and 50,gg/ml, respectively. From each of these three sources, a-fetoprotein was isolated by passage over an anti-a-fetoprotein immunoadsorbent column. Trace impurities were removed by subsequent passage over an anti-whole human serum immunoadsorbent column and Sephadex G-150, as described (1, 2). In addition, a-fetoprotein was isolated from a homogenate of fetal livers of 15-to 20-week-old stillborn human abortuses. All preparations of a-fetoprotein were pure as judged by immunoelectrophoresis and polyacrylamide gel electrophoresis (2). Lymphocyte transformation was assayed by triplicate cultures of 2 X 106 human peripheral blood lymphocytes in 1 ml of RPMI-1640 supplemented with 12.5% human heat-inactivated AB serum with addition of optimal doses of phytohemagglutinin (10 ytg/ml), concanavalin A (50 ,tg/ml), or antiserum against human thymocytes (25 'l/ml).